Finance

Lists
002688:SHE
Jinhe Biotechnology Co Ltd
CNÂ¥4.67
+0.86%
(+0.040) 1D
Nov 4, 3:04:09 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002688...
Open
CNÂ¥4.64
High
CNÂ¥4.68
Low
CNÂ¥4.58
Mkt. cap
3.88B
Avg. vol.
7.50M
Volume
6.41M
Dividend
2.14%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jun 1, 2026
P/E ratio
133.47
52-wk high
CNÂ¥7.00
52-wk low
CNÂ¥4.51
EPS
CNÂ¥0.03
Shares outstanding
837.38M
No. of employees
3K
Open
CNÂ¥4.64
High
CNÂ¥4.68
Low
CNÂ¥4.58
Mkt. cap
3.88B
Avg. vol.
7.50M
Volume
6.41M
Dividend
2.14%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jun 1, 2026
P/E ratio
133.47
52-wk high
CNÂ¥7.00
52-wk low
CNÂ¥4.51
EPS
CNÂ¥0.03
Shares outstanding
837.38M
No. of employees
3K
News stories
From web sources and news partners
About Jinhe Biotechnology Co Ltd
CEO-
Employees2.71K
FoundedMar 14, 1990
Headquarters-
SectorPharmaceutical industry
Industry-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
841.90M
741.88M
705.79M
646.73M
Cost of goods sold
596.11M
477.57M
431.75M
423.55M
Cost of revenue
596.11M
477.57M
431.75M
423.55M
Research and development expenses
30.94M
19.44M
22.65M
20.78M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
126.30M
136.75M
126.29M
158.95M
Operating expense
177.94M
160.24M
155.96M
170.73M
Total operating expenses
774.05M
637.80M
587.71M
594.28M
Operating income
67.85M
104.08M
118.08M
52.45M
Other non operating income
2.00M
-6.68M
4.30M
-77.98M
EBT including unusual items
-121.60M
76.97M
99.53M
10.24M
EBT excluding unusual items
42.27M
78.17M
92.22M
23.87M
Income tax expense
24.16M
13.63M
27.69M
10.00M
Effective tax rate
-19.87%
17.71%
27.83%
97.68%
Other operating expenses
18.61M
2.17M
6.98M
-7.06M
Net income
-111.51M
62.30M
68.60M
2.21M
Net profit margin
-13.25%
8.40%
9.72%
0.34%
Earnings per share
-
-
-
-
Interest and investment income
5.19M
1.06M
5.45M
41.44M
Interest expense
-24.00M
-20.29M
-21.15M
-6.50M
Net interest expenses
-18.80M
-19.22M
-15.71M
34.94M
Depreciation and amortization charges
-
-
-
-
EBITDA
125.26M
161.49M
180.89M
109.87M
Gain or loss from assets sale
2.73M
-
563.11K
-563.11K
Upcoming events
AI content may include mistakes. Learn more
Google apps